The association of bcl-2 expression with better outcome has been reported in lung (Pezzella et al, 1993; Fontanini et al, 1995), breast (Joensuu et al, 1994), colon (Baretton et al, 1996) and ovarian carcinomas (Diebold et al, 1996). This evidence concerns the gene BCL2 and ovarian carcinoma.